首页|门冬胰岛素30注射液对2型糖尿病患者血糖控制及安全性的影响

门冬胰岛素30注射液对2型糖尿病患者血糖控制及安全性的影响

扫码查看
目的 探究门冬胰岛素30注射液对2型糖尿病患者血糖控制及安全性的影响.方法 回顾性选取2021年1月—2023年5月单县中心医院收治的102例2型糖尿病患者的临床资料,根据治疗方式不同,分为对照组(二甲双胍)和观察组(二甲双胍+门冬胰岛素30注射液),各51例.对比两组临床疗效、血糖控制、胰岛素功能、不良反应.结果 观察组治疗总有效率高于对照组(96.08%vs 84.31%),差异有统计学意义(χ2=3.991,P= 0.046).治疗后观察组空腹血糖为(6.52±1.36)mmol/L、餐后2 h血糖为(9.08±1.53)mmol/L、糖化血红蛋白为(5.72±0.49)%,均低于对照组的(7.43±1.42)mmol/L、(10.16±1.67)mmol/L、(6.45±0.52)%,差异有统计学意义(t= 3.305、3.405、7.296,P均<0.05).治疗后观察组空腹胰岛素、胰岛素抵抗指数水平为(12.13±2.32)mU/L、(3.49±1.02),均高于对照组的(14.41±2.59)mU/L、(4.23±1.11),观察组胰岛素分泌指数水平为(94.71±5.46)低于对照组(82.57±5.98),差异有统计学意义(t=4.683、3.506、10.706,P均<0.05).观察组不良反应发生率低于对照组(5.88%vs 21.57%),差异有统计学意义(χ2=5.299,P=0.021).结论 2型糖尿病患者予门冬胰岛素30注射液治疗效果佳,不仅能有效控制血糖、改善胰岛素功能,且不良反应少.
The Effect of Insulin Aspart 30 Injection on Blood Glucose Control and Safety in Patients with Type 2 Diabetes Mellitus
Objective To explore the effect of insulin 30 aspartate injection on blood glucose control and safety in pa-tients with type 2 diabetes mellitus.Methods The clinical data of 102 patients with type 2 diabetes admitted to Shanx-ian Central Hospital from January 2021 to May 2023 were retrospectively selected.According to different treatment methods,they were divided into control group(metformin)and observation group(metformin + insulin aspartate 30 in-jection),with 51 cases in each group.The clinical efficacy,blood glucose control,insulin function and adverse reac-tions were compared between the two groups.Results The total effective rate of observation group was higher than that of control group(96.08%vs 84.31%),and the difference was statistically significant(χ2=3.991,P=0.046).After treat-ment fasting blood glucose was(6.52±1.36)mmol/L,2 h postprandial blood glucose was(9.08±1.53)mmol/L,and gly-cated hemoglobin A1c was(5.72±0.49)%in the observation group,which was lower than that of control group(7.43±1.42)mmol/L,(10.16±1.67)mmol/L and(6.45±0.52)%,and the differences were statistically significant(t=3.305,3.405,7.296,all P<0.05).After treatment fasting insulin and insulin resistance index in observation group were(12.13±2.32)mU/L and(3.49±1.02),which were higher than those in control group(14.41±2.59)mU/L and(4.23±1.11),the insulin secretion index of observation group(94.71±5.46)was lower than that of control group(82.57±5.98),and the differences were statistically significant(t=4.683,3.506,10.706,all P<0.05).The incidence of adverse reac-tions in observation group was lower than that in control group(5.88%vs 21.57%),and the difference was statistically significant(χ2=5.299,P=0.021).Conclusion Aspartate 30 injection is a safe and effective treatment for patients with type 2 diabetes,which not only clearly controls blood sugar and improves insulin function,but also has few adverse re-actions.

Type 2 diabetes mellitusInsulin aspart 30 injectionMetforminBlood glucose controlSafety

张华

展开 >

单县疾病预防控制中心慢性病防治门诊,山东菏泽 274300

2型糖尿病 门冬胰岛素30注射液 二甲双胍 血糖控制 安全性

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(5)
  • 16